Cervical spinal cord stimulation with 5-column paddle lead in Raynaud's disease

Pain Physician

Volumn 15, Issue 4, 2012, Pages 303-309

  Issa, Mohammed A ^a   Kim, Chong H ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Cervical pain; Electrode; Five column lead; Paresthesia; Penta lead; Programming; Raynaud disease; Spinal cord stimulation

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; VASODILATOR AGENT;

AGED; ARM PAIN; ARTICLE; CASE REPORT; CERVICAL SPINE; DISEASE SEVERITY; ELECTRODE; FOLLOW UP; FOOT PAIN; HAND PAIN; HUMAN; HYPOTENSION; INTERVERTEBRAL DISK DISEASE; LEG PAIN; LIFESTYLE MODIFICATION; LOW BACK PAIN; LUMBAR DISK HERNIA; LUMBAR SPINE; MALE; NECK PAIN; PAIN ASSESSMENT; RADIOFREQUENCY ABLATION; RAYNAUD PHENOMENON; SPINAL CORD STIMULATION; SPONDYLOSIS; SYMPATHETIC BLOCKING; ULCER;

AGED; CERVICAL VERTEBRAE; ELECTRODES, IMPLANTED; HUMANS; MALE; NECK PAIN; RAYNAUD DISEASE; SPINAL CORD STIMULATION;

EID: 84864425501     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Fogel GR, Esses SI, Calvillo O. Management of chronic limb pain with spinal cord stimulation. Pain Pract 2003; 3:144-151.
2. Holsheimer J, Nuttin B, King GW, Wesselink WA, Gybels JM, de Sutter P. Clinical evaluation of paresthesia steering with a new system for spinal cord stimulation. Neurosurgery 1998; 42:541-549.
3. Kumar K, Taylor RS, Jacques L, Eldabe S, Meglio M, Molet J, Thomson S, O'Callaghan J, Eisenberg E, Milbouw G, Buchser E, Fortini G, Richardson J, North RB. The effects of spinal cord stimulation in neuropathic pain are sustained: A 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery 2008; 63:762-770.
4. Amann W, Berg P, Gersbach P, Gamain J, Raphael JH, Ubbink DT; European Peripheral Vascular Disease Outcome Study SCS-EPOS. Spinal cord stimulation in the treatment of non-reconstructable stable critical leg ischaemia: results of the European Peripheral Vascular Disease Outcome Study (SCS-EPOS). Eur J Vasc Endovasc Surg 2003; 26:280-286
5. Sibell DM, Colantonio AJ, Stacey BR. Successful use of spinal cord stimulation in the treatment of severe Raynaud's disease of the hands. Anesthesiology 2005; 102:225-227.
6. Neuhauser B, Perkmann R, Klingler PJ, Giacomuzzi S, Kofler A, Fraedrich G. Clinical and objective data on spinal cord stimulation for the treatment of severe Raynaud's phenomenon. Am Surg 2001; 67:1096-1097.
7. Robaina FJ, Dominguez M, Diaz M, Rodriguez JL, de Vera JA. Spinal cord stimulation for relief of chronic pain in vasospastic disorders of the upper limbs. Neurosurgery 1989; 24:63-67.
8. Kumar K, Nath R, Wyant GM. Treatment of chronic pain by epidural spinal cord stimulation: A 10-year experience. J Neurosurg 1991; 75:402-407.
9. Alò KM, Holsheimer J. New trends in neuromodulation for the management of neuropathic pain. Neurosurgery 2002; 50:690-703.
10. Alò KM. Spinal Cord Stimulation for Complex Pain: 3 year Follow-up of Lead Positioning and Programming Strategies for Complex Pain with Computer Assisted and Patient Interactive Programming of Dual Octrodes. Proceedings of the International Neuromodulation Society. Number 85, Lucerne, Switzerland, September 1998.
11. Alò KM, Yland MJ, Redko V, Charnov JL, Kramer DL. Computer Assisted and Patient Interactive Programming of Dual Octrode Spinal Cord Stimulation in 173 Patients. Proceedings of the International Neuromodulation Society. Number 84, Lucerne, Switzerland. September 1998.
12. Alò KM. Lead programming and positioning strategies in complex pain. Neuromodulation 1999; 2:165-170.
13. Alò KM, Yland MI, Redko V, Charnov J. Multiple program spinal cord stimulation in the treatment of chronic pain: follow- up of multiple program SCS. Neuromodulation 1999; 2:266-272.
14. Richter E, Abramova M, Alò K. Low back paresthesia coverage with lateral programming of five-column paddle leads: technical report. JNSR 2011; 64-68.
15. Feler C, Garber J. Selective dermatome activation using a novel five-column spinal cord stimulation paddle lead: a case series. Presented at The North American Neuromodulation Society 13th Annual Meeting, Las Vegas, NV, December 3-6, 2009.
16. Washburn S, Norlin-Weissenrieder A, Young-Dixon B, Burns P. Technological innovation in spinal cord stimulation: the next generation of multi-column paddle leads. Abstract presented at the 14th Annual Meeting of the North American Neuromodulation Society, Las Vegas, NV, 2010.
17. May MS, Banks C, Thomson SJ. A retrospective, long term, third-party follow- up of patients considered for spinal cord stimulation. Neuromodulation 2002; 5:137-144.
18. De Jongste MJ, Nagelkerke D, Hooyschuur CM, Journée HL, Meyler PW, Staal MJ, de Jonge P, Lie KI. Stimulation characteristics, complications, and efficacy of spinal cord stimulation systems in patients with refractory angina: a prospective feasibility study. Pacing and Clinical Electrophysiology. 1994; 17:1751-1760.
19. Oakley JC, Espinosa F, Bothe H, McKean J, Allen P, Burchiel K, Quartey G, Spincemaille G, Nuttin B, Gielen F, King G, Holsheimer J. Transverse tripolar spinal cord stimulation: results of an international multicenter study. Neuromodulation 2006; 9:192-203.
20. Vallejo R, Kramer J, Benyamin R. Neuromodulation of the cervical spinal cord in the treatment of chronic intractable neck and upper extremity pain: A case series and review of the literature. Pain Physician 2007; 10:305-311.
21. Hagen JE, Bennett DS. Request for additional pertinent information regarding 4 extremity stimulation coverage from C2 spinal cord stimulation lead placement. Pain Physician 2007; 10:515-516
22. Hayek SM, Veizi E, Stanton-Hicks. Four-limb neurostimulation with neuroelectrodes placed in the lower cervical epidural space. Anesthesiology 2009; 110:681-684.
23. Arle JE, Shils JL. Method for implantation of a novel 5-column paddle lead in the cervical region of the spinal column. Las Vegas: Abstract-Poster presentation at North American Neuromodulation Society meeting; 2010.
24. Block JA, Sequeira W. Raynaud's phenomenon. Lancet 2001; 357:2042-2048.
25. Wigley FM. Clinical practice. Raynaud's Phenomenon. N Engl J Med 2002; 347:1001-1008.
26. Matsumoto Y, Ueyama T, Endo T, et al. Endoscopic thoracic sympathectomy for Raynaud's phenomenon. J Vasc Surg. 2002;36:57-61.
27. Maga P, Kuzdzal J, Nizankowski R, Szczeklik A, Sladek K. Long-term effects of thoracic sympathectomy on microcirculation in the hands of patients with primary Raynaud disease. J Thorac Cardiovasc Surg 2007; 133:1428-1433.
28. Thune TH, Ladegaard L, Licht PB. Thoracoscopic sympathectomy for Raynaud's phenomenon-a long term followup study. Eur J Vasc Endovasc Surg 2006; 32:198-202.
29. de Trafford JC, Lafferty K, Potter CE, Roberts VC, Cotton LT. An epidemiological survey of Raynaud's phenomenon. Eur J Vasc Surg 1988; 2:167-170.
30. Ubbink DT, Vermeulen H. Spinal cordstimulation for non-reconstructable chronic critical leg ischaemia. Cochrane Database Syst Rev 2005; 3:CD004001.
31. Tanaka S, Barron KW, Chandler MJ, Linderoth B, Foreman RD. Role of primary afferents in spinal cord stimulation-induced vasodilation: Characterization of fiber types. Brain Res 2003; 959:191-198.
32. Tanaka S, Barron KW, Chandler MJ, Linderoth B, Foreman RD. Low intensity spinal cord stimulation may induce cutaneous vasodilation via CGRP release. Brain Res 2001; 896:183-187.
33. Wu M, Linderoth B, Foreman RD. Putative mechanisms behind effects of spinal cord stimulation on vascular diseases: A review of experimental studies. Auton Neurosci 2008; 138:9-23.
34. Francaviglia N, Silvestro C, Maiello M, Bragazzi R, Bernucci C. Spinal cord stimulation for the treatment of progressive systemic sclerosis and Raynaud's syndrome. Br J Neurosurg 1994; 8:567-571.